June 15th - 2010
Futures presentations at the ICS 2010
Pelvipharm at the 40th annual meeting of the International Continence Society (ICS) in Toronto, Canada, 23 – 27 August 2010.
Pelvipharm will present 4 posters:
- "A new experimental rat model combining both dynamic and static components of voiding LUTS/BPH: consequence on bladder function"
- "Vardenafil decreases bladder afferent nerve activity in unanesthetized decerebrate spinal cord-injured rats"
- "Nitric oxide/cGMP signaling mediates an inhibitory action on sensory pathways of the micturition reflex in the rat"
- "Rho-kinase inhibition relaxes detrusor from neurogenic patients"
Please come and see us, we will be happy to discuss our results with you and potential applications for you.
March 9th - 2010
Future presentations at the WorldPharma 2010
Pelvipharm at the 16th World Congress of Basic and Clinical Pharmacology in Copenhaguen, Denmark, 17 – 23 July 2010.
François Giuliano will be the conference leader of the focused conference "Developments in the treatment of sexual dysfunction and diseases of the lower urinary tract".
François Giuliano will chair the session "Pharmacological treatment of lower urinary tract syndrome/benign prostatic hyperplasia" and will give a lecture on "Central pharmacological targets for the treatment of ejaculatory disorders".
In the session "Treatment of sexual dysfunction associated with cardiovascular disease", Delphine Behr-Roussel will give a lecture on "Animal models for sexual dysfunction and cardiovascular disease".
Furthemore, Pelvipharm will present 2 posters :
- "Rho-kinase inhibition relaxes detrusor from neurogenic patients"
- "Rho-kinase inhibition impacts neurogenic detrusor overactivity in chronic spinalized rats"
Please come and see us, we will be happy to discuss our results with you and potential applications for you.
June 21st - 2010
Euro-Biotech Forum in Paris, June 2010
Pelvipharm will be represented by Delphine Behr-Roussel at the next Euro-Biotech Forum in Paris, June 28-30, 2010. We warmly invite you to take this opportunity to learn more about our services.
If you’d like to set up a specific meeting at any time throughout the conference, please email staffpelvipharm@pelvipharm.com and we will be happy to assist you.
May 17th - 2010
European Partnering and Investment Conference in London, June 2010
Pelvipharm will be represented by Delphine Behr-Roussel at the next European Partnering and Investment Conference (EPIC) in London, June 23th 2010. We warmly invite you to take this opportunity to learn more about our services.
If you’d like to set up a specific meeting at any time throughout the conference, please email staffpelvipharm@pelvipharm.com and we will be happy to assist you.
April 7th - 2010
Future presentations at the AUA 2010
Pelvipharm at the AUA (American Urological Association) in San Francisco, USA, 29 may – 3 june 2010.
Pelvipharm will present 2 Moderated posters :
January 11th - 2010
Future presentations at the EAU 2010
Pelvipharm at the EAU (European Association of Urology) in Barcelona, Spain, 16 - 20 April 2010.
Pelvipharm will present 5 Posters:
- "Vardenafil decreases bladder afferent nerve activity in unanesthetized decerebrate spinal cord-injured rats"
- "Combined effect of a phosphodiesterase 5 inhibitor, udenafil, with an antimuscarinic, oxybutynin on human detrusor relaxation"
- "Rho-kinase inhibition impacts neurogenic detrusor overactivity in chronic spinalized rats"
- "Rho-kinase inhibition relaxes detrusor from neurogenic patients"
- "Nitric oxide/cGMP signalling mediates an inhibitory action on sensory pathways of the micturition reflex
in the rat"
Please come and see us, we will be happy to discuss our results with you and potential applications for you.
